Biological E#39;s COVID Vaccine: Govt to pay Rs 1500 crore advance to procure 30 crore doses

The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.

from Moneycontrol Business News https://ift.tt/3phhqth